Not Yet Recruiting NA INTERVENTIONAL 2-arm NCT05918770

Side Effects Screening and Early Intervention to Impact in Quality of Life of Gynaecological Cancer Patients (HALIS)

Telemedicine-guided Patients Reported Outcome Measures (PROMs): Side Effects Screening and Early Intervention to Impact in Quality of Life of Gynaecological Cancer Patients

Sponsor: Hospital Universitario 12 de Octubre

Conditions Gynaecological Cancer Lymphedema, Lower Limb Quality of Life Sexual Dysfunction

Interventions systematic screening and early treatment

Updated 3 times since 2023 Last updated: Jun 23, 2023 Started: Sep 30, 2023 Primary completion: Sep 30, 2026 Completion: Sep 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Gynaecological Cancer and Lymphedema, Lower Limb, this trial is actively recruiting participants. The trial is conducted by Hospital Universitario 12 de Octubre and has accumulated 3 data snapshots since 2023. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Not Yet Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
Jul 2023 — Jul 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Universitario 12 de Octubre

Data source: Hospital Universitario 12 de Octubre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.